Results 61 to 70 of about 326,926 (265)

Development and validation of an early diagnostic model to distinguish bacterial infection in patients with acute-on-chronic liver disease (AoCLD) and systemic inflammatory response syndrome (SIRS): a post-hoc analysis of a prospective multicenter cohort

Journal of Advanced Research
Background and objectives: Early differentiation between infectious and non-infectious systemic inflammatory response syndrome (SIRS) in patients with acute-on-chronic liver disease (AoCLD) remains challenging. This study aimed to develop and validate an
Hui Zhou, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Jinjun Chen, Zhongji Meng, Yubao Zheng, Yanhang Gao, Zhiping Qian, Feng Liu, Xiaobo Lu, Yu Shi, Jia Shang, Yan Huang, Ruochan Chen   +15 more
doaj   +1 more source

BREAKTHROUGH ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS D

Актуальные проблемы теоретической и клинической медицины
For a long period of 46 years since the discovery of the hepatitis D virus antigen by M. Rizzetto in 1977, chronic hepatitis D was considered in conjunction with chronic hepatitis B, classified as chronic hepatitis B with the delta agent.
D. I. Otunbayeva, B. K. Nurgalieva, S. S. Kariyeva   +2 more
doaj   +1 more source

Perihepatic lymphadenopathy in children with chronic viral hepatitis

Journal of Ultrasonography, 2015
Objective. To assess whether lymph node enlargement in the hepatoduodenal ligament occurs in children with chronic viral hepatitis B and C in comparison to healthy controls. Subject and methods.
Dagmar Schreiber-Dietrich, Margret Pohl, Xin-Wu Cui, Barbara Braden, Christoph F. Dietrich, Liliana Chiorean   +5 more
doaj   +1 more source

A concise assessment of salivary modifications in patients with chronic hepatitis [PDF]

Romanian Journal of Medical Practice, 2017
Background. Saliva is a complex biological fluid that has great potential as a diagnosis fluid for both oral and systemic diseases. At the same time, chronic hepatitis affects millions of people worldwide and can lead to liver cirrhosis and ...
Daniela-Gabriela BADITA, Dan PIPEREA-SIANU, Andra-Elena BALCANGIU-STROESCU, Bogdan CALENIC, Maria GREABU, Maria-Daniela TANASESCU, Laura RADUCU, Iulia-Ioana STANESCU   +7 more
doaj   +1 more source

Treatment of chronic hepatitis

BMJ, 2001
Viral hepatitis is the major cause of chronic liver disease worldwide. An estimated 300 million people are carriers of the hepatitis B virus, and 120 million are infected with hepatitis C. Untreated, these infections may progress to cirrhosis, liver failure, and hepatoma.
P J, Gow, D, Mutimer
openaire   +3 more sources

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

REGIONAL PATTERNS OF THE SPREAD OF HEPATITIS B AND C AMID THE COVID-19 PANDEMIC AND FULL-SCALE WAR: 2019–2025

Проблеми екології та медицини
Introduction. The incidence of viral hepatitis B and C in Ukraine has undergone significant changes and a geographical redistribution in recent years against the backdrop of the COVID-19 pandemic and a full-scale war, both of which have significantly ...
O.G. Marchenko, N.O. Pryimenko, V.A. Bodnar, T.I. Koval, M.Yu. Peka, O.A. Shlykova, O.V. Izmaylova, G.Yu. Morokhovets, A.V. Kabaley, D.I. Gorobets, V.V. Palchik, I.P. Kaidashev   +11 more
doaj   +1 more source

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

Arthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin, Candace H. Feldman, Claire E. H. Barber, Gabriel Fabreau, Jake Jennings, Scott Patten, Cheryl Barnabe, Inflammatory Arthritis‐Specific ACSC Consensus Process Working Group   +7 more
wiley   +1 more source

Elevated Liver Enzymes Is Not an Impediment to Allopurinol Dose Escalation: An Observational Cohort Study

Arthritis Care &Research, EarlyView.
Objective Routine liver enzyme monitoring is advocated for while on allopurinol, but supporting guidance is lacking. We assessed the incidence and factors associated with elevated liver enzyme levels in patients with gout commenced on allopurinol. Methods One hundred and fifty patients with gout and normal baseline serum aminotransferases initiated on ...
May Shuen Tang, Qai Ven Yap, Peter Pak Moon Cheung, Amelia Santosa, Gim Gee Teng   +4 more
wiley   +1 more source

Real‐World Safety of Concomitant Colchicine and Statin Therapy

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the risk of clinically meaningful muscle‐ and liver‐related outcomes associated with concomitant colchicine–statin therapy in a real‐world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone.
Roni Meidan, Ranel Loutati, Dan Caspi, Ori Elkayam, Ran Abuhasira, Tali Eviatar   +5 more
wiley   +1 more source